Tamoxigenat, created in 1986 (Germany), from 2951 sister brands and 17477 competing brands. Tamoxigenat is owned by NOVARTIS N, listed on the stock exchange of Zurich The ISIN, the company's International Securities Identification Number, is CH0012005267. Tamoxigenat belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(Tamoxigenat)
over 5 years*
CHF 100.35